People · Operator
Named in public records as an officer, director or promoter · active 2021–2021 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Biothea Pharma, Inc. | — | Biotechnology | Series B | $22.0M | $553.8M | 2021 |
Torbjorn J. Bjerke at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Torbjorn J. Bjerke on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Marina S. Bozilenko | 1 | 1 |
| Anthony J. Aiudi | 1 | 1 |
| Andrea J. Corcoran | 1 | 1 |
| Jean-Pierre J. Sommadossi, Ph.D. | 1 | 1 |
| Rohit J. Mehta | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.